A PYMNTS Company

Federal Agencies Investigate Private-Equity Impact on Healthcare Costs

 |  March 5, 2024

Federal agencies are calling for public input to examine the repercussions of corporate dominance on patient care quality, worker safety, and healthcare affordability.

The initiative, spearheaded by regulatory bodies, seeks to dissect the effects of corporate transactions that may not trigger antitrust reviews mandated by existing legislation. With the issuance of a Request for Information (RFI), the agencies have invited commentary on transactions involving healthcare providers and facilities, emphasizing concerns that financial maneuvers could potentially compromise the integrity of healthcare delivery, reported the Wall Street Journal.

FTC Chair Lina M. Khan underscored the negative impacts of practices such as staffing cuts following buyouts, highlighting the inquiry’s pivotal role in curtailing strategies that prioritize profit over patient welfare. The inquiry, she noted, aims not only to address current concerns but also to proactively preserve competition within healthcare markets.

This proactive approach underscores the agencies’ commitment to crafting policies that foster a competitive, high-quality, and accessible healthcare landscape. By soliciting insights from a diverse array of stakeholders, including patients, healthcare workers, and industry experts, the agencies aspire to catalyze significant positive changes in the sector.

Research has consistently emphasized the crucial role of competition in driving innovation, enhancing quality, and containing costs within healthcare. Therefore, the inquiry holds the potential to spark meaningful transformations that benefit both patients and healthcare workers alike.

As the public consultation period begins, stakeholders are encouraged to participate actively in shaping the future of healthcare, ensuring that policies are formulated with the best interests of patients and medical professionals in mind. The outcome of this inquiry could have far-reaching implications for the healthcare industry, reshaping the landscape to prioritize the well-being of those it serves.

Source: WSJ